Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.870 USD | -1.86% |
|
+14.48% | +13.16% |
| Market Cap | 246M 330M 285M 262M 462M 31.22B 467M 3.1B 1.21B 15.29B 1.24B 1.21B 52.98B | P/E Ratio 2026 * |
-11.2x | P/E Ratio 2027 * | -11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 93.35M 125M 108M 99.43M 175M 11.85B 177M 1.17B 458M 5.8B 470M 460M 20.1B | EV / Sales 2026 * |
32.7x | EV / Sales 2027 * | -11.7x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | -1.86% | ||
| 1 week | +14.48% | ||
| Current month | -0.29% | ||
| 1 month | +10.43% | ||
| 3 months | -6.39% | ||
| 6 months | +9.73% | ||
| Current year | +13.16% |
| 1 week | 5.91 |  | 7.18 |
| 1 month | 5.74 | | 7.29 |
| Current year | 4.19 | | 8.4 |
| 1 year | 4.19 | | 8.4 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 28.35 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 2025-12-13 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 2022-02-20 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 2020-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 2018-06-20 |
Iain Ross
CHM | Chairman | 72 | 2019-11-30 |
Rhonda Hellums
BRD | Director/Board Member | 54 | 2025-12-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-01 | Free | Chief Technology Officer | 300,000 | 0.2117% | ||
| 01-01 | Free | Chief Financial Officer | 375,000 | 0.2646% | ||
| 01-01 | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.86% | +14.48% | +35.97% | +3.61% | 331M | |
| -0.12% | -0.18% | -12.80% | -12.90% | 43.58B | |
| -2.47% | +4.81% | +294.14% | +536.68% | 34.03B | |
| +0.59% | -3.55% | +12.81% | -16.84% | 29.77B | |
| -0.64% | -0.49% | +0.92% | +33.29% | 29.82B | |
| -0.29% | +9.47% | +13.95% | +21.93% | 25.42B | |
| +4.89% | +9.08% | - | - | 13.87B | |
| -0.70% | -0.38% | +54.50% | +109.63% | 13.35B | |
| -1.04% | -3.48% | +2.42% | +1.98% | 12.85B | |
| -1.05% | -1.99% | +107.41% | +78.19% | 12.22B | |
| Average | -0.25% | +3.06% | +56.59% | +83.95% | 21.52B | |
| Weighted average by Cap. | -0.31% | +2.03% | +61.07% | +105.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.86M 3.83M 3.3M 3.04M 5.36M 362M 5.42M 35.95M 14.01M 178M 14.39M 14.08M 615M | 4.12M 5.53M 4.77M 4.39M 7.74M 523M 7.82M 51.88M 20.21M 256M 20.76M 20.32M 888M |
| Net income | -49.09M -65.88M -56.78M -52.28M -92.16M -6.23B -93.14M -618M -241M -3.05B -247M -242M -10.57B | -80.04M -107M -92.57M -85.24M -150M -10.16B -152M -1.01B -392M -4.97B -403M -395M -17.24B |
| Net Debt | -153M -205M -177M -163M -287M -19.38B -290M -1.92B -749M -9.49B -769M -753M -32.88B | -294M -395M -340M -313M -553M -37.35B -558M -3.7B -1.44B -18.29B -1.48B -1.45B -63.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 6.880 $ | -1.71% | 127,584 |
| 26-06-15 | 7.000 $ | +4.63% | 406,276 |
| 26-06-12 | 6.690 $ | +0.15% | 239,402 |
| 26-06-11 | 6.680 $ | +11.33% | 700,918 |
| 26-06-10 | 6.000 $ | -0.17% | 140,944 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
